Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;23(2):431-41.
doi: 10.1007/s10856-011-4494-1. Epub 2011 Nov 22.

Design and Synthesis of Dual-Ligand Modified Chitosan as a Liver Targeting Vector

Affiliations

Design and Synthesis of Dual-Ligand Modified Chitosan as a Liver Targeting Vector

Houxiang Chen et al. J Mater Sci Mater Med. .

Abstract

Vector plays an important role in hepatic targeted drug delivery system. In this study, a novel material as a liver targeting vector, dual-ligand modified chitosan (GCGA) composed of chitosan (CTS), glycyrrhetinic acid (GA) and lactobionic acid (LA), was designed and synthesized by an orthogonal experiment with two-step synthesis under mild conditions. The synthesized final product was characterized and confirmed by FTIR and (1)H-NMR spectroscopy, and DS of GA and LA in CTS were measured to be 13.77 and 16.74 mol% using (1)H-NMR, respectively. The cytotoxicity of CTS and GCGA was concentration dependent which was inverse proportion to the cell viability by MTT assay using L929 cell line, and inhibitory concentration 50% (IC50) was 0.2 mg/ml for GCGA. The in vitro targeting efficiency and the in vitro cellular uptake were investigated. Compared with CTS NPs and GA-CTS NPs, GCGA NPs showed good cell specificity to BEL-7402 cells via the dual-ligand-receptor-mediated recognition, leading to a higher affinity to BEL-7402 cells. The results suggested that GCGA described here has the potential to be used as an effective vector for hepatic targeted drug therapy.

Similar articles

See all similar articles

Cited by 4 articles

References

    1. Int J Biol Macromol. 2011 Nov 1;49(4):543-7 - PubMed
    1. J Biol Chem. 1980 Oct 10;255(19):9033-6 - PubMed
    1. Bioconjug Chem. 1994 Nov-Dec;5(6):547-56 - PubMed
    1. J Control Release. 2004 Nov 5;100(1):5-28 - PubMed
    1. Cancer Lett. 1990 Jan;49(1):9-12 - PubMed

Publication types

LinkOut - more resources

Feedback